What does an earnings surprise mean?

An earnings surprise is the difference between a company's reported EPS or revenue and the analysts' consensus estimate. A positive surprise means results exceeded expectations, while a negative surprise means results fell short.

How can earnings reports affect MDT stock?

Earnings reports can increase volatility in MDT stock, especially when reported EPS, revenue or company guidance differs from market expectations. An earnings beat does not always lead to a price increase, as investors also consider the outlook, valuation and broader market conditions.

Medtronic PLC Earnings Dates & Reports

This page offers detailed Medtronic PLC earnings data including the latest Medtronic PLC earnings report, the upcoming Medtronic PLC earnings date, historical data and Medtronic PLC earnings call news.

MDT Latest Quarter’s Earnings

Announce Date9/1/2026

EPS Actual (USD)1.15

Revenue Actual (USD)9.76B

MDT Upcoming Quarter's Earnings

Announce Date--

EPS Forecast (USD)--

Revenue Forecast (USD)--

MDT FY2026 Earnings

EPS (YoY)3.753.29%

Revenue (YoY)36.36B8.43%

Medtronic PLC (MDT) Earnings History

Release Date	Period End	EPS/Forecast	Revenue/Forecast	EPS Surprise %	Revenue Surprise %
9/1/2026	03/2027	1.15/1.39	9.76B/9.54B	-17.24%	2.21%
6/3/2026	12/2026	0.97/1.54	9.81B/9.63B	-36.99%	1.81%
2/17/2026	09/2026	0.89/1.33	9.02B/8.91B	-33.23%	1.26%
11/18/2025	06/2026	1.07/1.31	8.96B/8.87B	-18.47%	1.08%
8/19/2025	03/2026	0.81/1.23	8.58B/8.38B	-33.99%	2.39%
5/21/2025	12/2025	0.82/1.58	8.93B/8.82B	-47.84%	1.17%
2/18/2025	09/2025	1.01/1.36	8.29B/8.32B	-25.80%	-0.39%
11/19/2024	06/2025	0.99/1.25	8.40B/8.27B	-20.68%	1.59%

Medtronic PLC Latest Earnings Call Transcripts

Medtronic (MDT) Fiscal Q1 2027 Earnings Call: Revenue Growth and Guidance Raised

Medtronic’s fiscal Q1 2027 revenue rose 13.7% to $9.8 billion, led by cardiac ablation, as management raised its full-year growth and EPS guidance.

Medtronic PLC Earnings News

Medtronic Q1 FY2027 Earnings: Broad Portfolio Growth Supports Higher Guidance

Medtronic’s fiscal Q1 2027 revenue rose 13.7% to $9.756 billion, while GAAP diluted EPS increased 40.7% to $1.14 and non-GAAP EPS grew 15.1% to $1.45. Cardiovascular led broad portfolio growth, and free cash flow more than doubled to $1.290 billion. An extra fiscal week contributed about $570 million to organic revenue, affecting year-over-year comparability. Medtronic raised FY2027 organic growth guidance to 7.25%–7.75% and narrowed non-GAAP EPS guidance to $5.94–$6.00.

TradingKeyTue, Sep 1

Medtronic PLC